EMBASE

EMBASE
Name	EMBASE
Producer	Elsevier
Country	Netherlands
History	1947–present
Disciplines	Biomedical and pharmacological literature
Formats	Abstracts, indexing, controlled vocabulary
Access	Subscription

EMBASE

EMBASE is a comprehensive biomedical and pharmacological bibliographic database produced by Elsevier, widely used alongside PubMed, MEDLINE, Cochrane Library, and Scopus in systematic reviews, clinical guideline development, drug safety surveillance, and pharmacovigilance. Researchers, clinicians, regulatory agencies such as the European Medicines Agency and the U.S. Food and Drug Administration rely on EMBASE for literature retrieval when preparing submissions, assessments, and evidence syntheses related to trials, case reports, and adverse drug reactions.

Overview

EMBASE indexes journals, conference abstracts, and grey literature with emphasis on pharmacology, drug research, and European publications, complementing PubMed Central, Web of Science, and PsycINFO. It includes a controlled thesaurus, the Emtree, enabling mapping between terms used in disparate sources such as ClinicalTrials.gov, WHO International Clinical Trials Registry Platform, and regional registries like the European Clinical Trials Database. Major stakeholders include academic institutions like Johns Hopkins University, regulatory bodies such as the Medicines and Healthcare products Regulatory Agency, and industry players including Pfizer, Roche, and Novartis.

History and Development

EMBASE originated in the mid-20th century under Elsevier, evolving in parallel with databases such as Index Medicus and BIOSIS. Key milestones include expansion of conference coverage during the 1980s, introduction of online platforms in the 1990s concurrent with services like OVID and EBSCOhost, and integration with citation platforms like Scopus in the 2000s. Collaborations and developments intersected with institutions such as Cochrane Collaboration, technology vendors like Elsevier ScienceDirect, and standards bodies including the National Library of Medicine. EMBASE’s growth responded to needs highlighted by incidents involving pharmacovigilance investigations at regulators like the European Medicines Agency and high-profile safety reviews by companies such as GlaxoSmithKline.

Content and Coverage

EMBASE indexes millions of records from thousands of sources, encompassing journals published by groups such as Springer Nature, Wiley-Blackwell, and BMJ Publishing Group. Coverage prioritizes pharmacology, toxicology, drug research, clinical trials, device literature, and conference abstracts from societies like the American Heart Association, European Society of Cardiology, and American Society of Clinical Oncology. It captures literature spanning randomized controlled trials reported in journals like The Lancet, New England Journal of Medicine, and JAMA, as well as specialty outlets such as The Journal of Pharmacology and Experimental Therapeutics and Annals of Internal Medicine. International content sources include publishers in regions represented by institutions like Karolinska Institutet, University of Tokyo, and Imperial College London.

Search Features and Indexing

EMBASE provides structured searching via the Emtree thesaurus, facilitating term explosion, automatic mapping, and synonym control similar to subject heading systems used by National Library of Medicine for MeSH. Advanced search capabilities parallel offerings from OvidSP and EBSCOhost, enabling Boolean operators, proximity searching, and filters for study design types like randomized trials, cohort studies, and case reports often reported in venues such as The BMJ and Annals of Surgery. Indexing practices include assignment of Emtree terms, drug identifiers cross-referenced with regulatory nomenclature from the U.S. Food and Drug Administration, and linking to trial registry entries such as ClinicalTrials.gov.

Access and Licensing

Access to EMBASE is subscription-based, with institutional and commercial licenses managed by Elsevier and offered via platforms like ScienceDirect and third-party vendors including Ovid Technologies. Licensing agreements vary among universities (e.g., Harvard University, University of Oxford), hospitals (e.g., Mayo Clinic, Cleveland Clinic), and pharmaceutical companies (e.g., AstraZeneca, Merck & Co.), and often include campus-wide or enterprise access, usage metrics, and integration with discovery services such as Ex Libris and EBSCO Discovery Service.

Impact and Use in Research and Healthcare

EMBASE significantly influences systematic reviews, health technology assessments, and drug safety studies commissioned by organizations like the National Institute for Health and Care Excellence, World Health Organization, and national health agencies including Public Health England. Clinicians at teaching hospitals such as Massachusetts General Hospital and researchers at centers like Dana-Farber Cancer Institute use EMBASE to locate trial reports, adverse event case series, and pharmacokinetic studies informing treatment guidelines by bodies such as the American College of Cardiology and European Respiratory Society. Its coverage of conference abstracts supports early identification of emerging evidence relevant to professional societies like European Society for Medical Oncology.

Comparison with Other Databases

Compared with PubMed and MEDLINE, EMBASE offers broader European and pharmacology-oriented coverage, including more conference abstracts and industry literature often indexed by publishers like IEEE for related biomedical engineering content. Relative to Scopus and Web of Science, EMBASE emphasizes controlled vocabulary and drug indexing via Emtree, while Scopus provides expansive citation metrics connected to institutions such as Cornell University and Stanford University. For evidence synthesis, reviewers commonly search EMBASE in addition to Cochrane Library and PubMed Central to reduce publication bias and capture grey literature from sources linked to entities like Society for Investigative Dermatology and American Association for Cancer Research.

Category:Bibliographic databases